15th Anniversary Edition of the C-MAP™ Canadian Drug Benefit Plans Reference Guide

Home 15th Anniversary Edition of the C-MAP™ Canadian Drug Benefit Plans Reference Guide

The C-MAP™ Canadian Drug Benefit Plans Reference Guide is the authoritative source for comprehensive and up-to-date information on Canadian reimbursement and market access for pharmaceutical market access specialists. The publication highlights each of the relevant agencies, organizations and drug plans operating in the market access and reimbursement environment in Canada. This valuable information can assist market access professionals in achieving timely and optimal reimbursement.

Features ofthe C-MAP™ Canadian Drug Benefit Plans Reference Guide include:

  1. An executive summary providing essential facts for each drug plan in a convenient tabular format for quick and easy reference
  2. An Executive Briefing on the Pharmaceutical Pricing and Reimbursement Landscape in Canada
  3. An extensive section on the Common Drug Review (CDR) providing a comprehensive description of the CDR process and procedures, including:
    • CDR rationale for the Canadian Drug Expert Committee (CDEC) decisions
    • Time to decision tracking of submissions
    • Submission requirement checklists
    • CDR submission forms and templates available online
  4. Detailed overviews of the pan-Canadian Oncology Drug Review (pCODR), Provincial Cancer Programs, the Patented Medicine Prices Review Board (PMPRB), the Canadian Agency for Drugs and Technologies in Health (CADTH), Blood Agencies, Public Health Vaccines and Private Drug Plans
  5. Individual chapters on each of the federal, provincial and territorial prescription drug programs in Canada, including:
    • Contextual background on formulary listing policies and procedures
    • Detailed guides to the submission requirements necessary to achieve reimbursement

In addition, the 15th Anniversary Edition will feature new sections on:

  1. The Health Canada Special Access Program
  2. Drugs for Rare Diseases
  3. Hospital Drugs
  4. CDR Submissions for Subsequent Entry Biologics
  5. Enhanced Private Payer information

It is organized to be an accessible and easy to use source to guide professionals through the increasingly complex market access landscape in Canada.

The annual subscription cost for the 15th Anniversary Edition of the C-MAP™ Canadian Drug Benefit Plans Reference Guide is $8,450.00 (plus HST/GST).  For more information, or to place an order, please visit our website or contact Courtney Nelson at 613-742-8225 ext.26 or Courtney.Nelson@pdci.ca

/ News